Germans to be Denied Benlysta Coverage
Thursday, May 3, 2012
Germany joins the UK in rejecting healthcare coverage for Benlysta, a new drug for lupus from GlaxoSmithKline and Human Genome Sciences.
Please visit http://www.thepetitionsite.com/1/cover-Benlysta/ to sign a petition calling for NICE to reconsider its position. The petition may help influence German authorities if NICE reconsiders its recommendation.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms